Abstract
Purpose
To investigate whether the serum total oxidant status (TOS), total antioxidant status (TAS), advanced oxidation protein products (AOPP), and thiol parameters could play a role in the pathogenesis of non-arteritic anterior ischemic optic neuropathy (NA-AION).
Methods
In this study, 18 newly diagnosed NA-AION patients and 17 healthy subjects (control group) were included. Serum plasma TOS and TAS, AOPP, and thiol parameters were measured by spectrophotometric method and the results were compared.
Results
Mean age of the patients and the controls were 60.8 ± 8.4 and 61.9 ± 9.4 years, respectively (p = 0.729). There were no significant differences between the patients and the control group with regard to the values of TAS, TOS, AOPP, and thiol (p = 0.869, p = 0.863, p = 0.040, p = 0.314; respectively). There was a positive correlation between TOS and thiol (p = 0.002, r = 0.681).
Conclusion
We found no significant relationship between systemic oxidative parameters and NA-AION. However, this study should be accepted as a pilot investigation and needs to be validated.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Rucker JC, Biousse V, Newman NJ. Ischemic optic neuropathies. Curr Opin Neurol. 2004;17:27–35.
Hattenhauer MG, Leavitt JA, Hodge DO, Grill R, Gray DT. Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol. 1997;123:103–7.
Johnson LN, Arnold AC. Incidence of nonarteritic and arteritic anterior ischemic optic neuropathy. Population-based study in the state of Missouri and Los Angeles County, California. J Neuroophthalmol. 1994;14:38–44.
Buono LM, Foroozan R, Sergott RC, Savino PJ. Nonarteritic anterior ischemic optic neuropathy. Curr Opin Ophthalmol. 2002;13:357–61.
Newman NJ, Scherer R, Langenberg P, Kelman S, Feldon S, Kaufman D, et al. The fellow eye in NAION: report from the ischemic optic neuropathy decompression trial follow-up study. Am J Ophthalmol. 2002;134:317–28.
Hayreh SS. Acute ischemic disorders of the optic nerve: pathogenesis, clinical manifestations, and management. Ophthalmol Clin North Am. 1996;9:407–42.
Newman NJ, Dickersin K, Kaufman D, Kelman S, Scherer R. Characteristics of patients with non arteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial. Arch Ophthalmol. 1996;114:1366–74.
Arnold AC. Pathogenesis of nonarteritic anterior ischemic optic neuropathy. J Neuroophthalmol. 2003;23:157–63.
Palombi K, Renard E, Levy P, Chiquet C, Deschaux Ch, Romanet JP, et al. Non-arteritic anterior ischaemic optic neuropathy is nearly systematically associated with obstructive sleep apnea. Br J Opthalmol. 2006;90:879–82.
Erel O. A novel automated method to measure total antioxidant response against potent free radical reactions. Clin Biochem. 2004;37:112–9.
Friguet B. Protein repair and degradation during aging. Sci World J. 2002;2:248–54.
Cance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev. 1979;59:527–605.
Davies KJA. Protein damage and degradation by oxygen radicals. J Biol Chem. 1987;262:9902–7.
Flammer J, Mozaffarieh M. What is the present pathogenetic concept of glaucomatous optic neuropathy? Surv Ophthalmol. 2007;52:162–73.
Liu Q, Ju WK, Crowston JG, Xie F, Perry G, Smith MA, et al. Oxidative stress is an early event in hydrostatic pressure-induced retinal ganglion cell damage. Invest Ophthalmol Vis Sci. 2007;48:4580–9.
Garcia-Valenzuela E, Shareef S, Walsh J, Sharma SC. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res. 1995;61:33–44.
Ocakoglu O, Balcı H, Ozkök A, Dinçer Y, Koç EE, Uçar D, et al. Primer açık açılı glokomlu ve senil kataraktlı hastalarda oksidatif stresin rolü. T Oft Gaz. 2008;38:292–7.
Bokov A, Chaudhuri A, Richardson A. The role of oxidative damage and stress in aging. Mech Ageing Dev. 2004;125:811–26.
Moriarty-Craige SE, Adkinson J, Lynn M, Gensler G, Bressler S, Jones DP, et al. Antioxidant supplements prevent oxidation of cysteine/cystine redox in patients with age-related macular degeneration. Am J Ophthalmol. 2005;140:1020–6.
Zoric L, Miric D, Milenkovic S, Jovanovic P, Trajkovic G. Pseudoexfoliation syndrome and its antioxidative protection deficiency as risk factors for age-related cataract. Eur J Ophthalmol. 2006;16:268–73.
Ferreira SM, Lerner SF, Brunzini R, Evelson PA, Llesuy SF. Oxidative stress markers in aqueous humor of glaucoma patients. Am J Ophthalmol. 2004;137:62–69.
Balci M, Sahin S, Mutlu FM, Yagci R, Karanci P, Yildiz M. Investigation of oxidative stress in pterygium tissue. Mol Vision. 2011;17:443–7.
Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, Nguyen-Khoa T, Nguyen AT, Zingraff J, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int. 1996;49:1304–13.
Hu ML, Loue S, Cross CE, Motchnik P, Halliwell B. Antioxidant protection against hypochlorous acid in human plasma. J Lab Clin Med. 1993;121:257–62.
Erel O. A new automated colorimetric method for measuring total oxidant status. Clin Biochem. 2005;38:1103–11.
Beri M, Klugman M, Kohler J, Hayreh SS. Anterior ischemic optic neuropathy. Ophthalmology. 1987;94:1020–8.
Venkataraman ST, Flanagan JG, Hudson C. Vascular reactivity of optic nerve head and retinal blood vessels in glaucoma—a review. Microcirculation. 2010;17:568–81.
Flammer J. The vascular concept of glaucoma. Surv Ophthalmol. 1994;38:3–6.
Hayreh S. Factors influencing blood flow in the optic nevre head. J Glaucoma. 1997;66:412–25.
Horoz M, Bolukbas C, Bolukbas FF, Aslan M, Koylu AO, Selek S, et al. Oxidative stress in hepatitis C infected end-stage renal disease subjects. BMC Infect Dis. 2006;6:114.
Kersten E, Paun CC, Schellevis RL, Hoyng CB, Delcourt C, Lengyel I, et al. Systemic and ocular fluid compounds as potential biomarkers in age-related macular degeneration. Surv Ophthalmol. 2018;63:9–39.
Toprak I, Kucukatay V, Yildirim C, Kilic-Toprak E, Kilic-Erkek O. Increased systemic oxidative stress in patients with keratoconus. Eye. 2014;28:285–9.
Engin KN, Yemisci B, Yigit U, Agachan A, Coskun C. Variability of serum oxidative stress biomarkers relative to biochemical data and clinical parameters of glaucoma patients. Mol Vis. 2010;16:1260–71.
Baskol G, Gumus K, Oner A, Arda H, Karakucuk S. The role of advanced oxidation protein products and total thiols in diabetic retinopathy. Eur J Ophthalmol. 2008;18:792–798.34.
Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med. 2001;30:1191–212.
Flammer J. Glaucomatous optic neuropathy: a reperfusion injury. Klin Mon Augenheilkd. 2001;218:290–1.
Kim JM, Kim YJ, Kim DM. Increased expression of oxyproteins in the optic nerve head of an in vivo model of optic nerve ischemia. BMC Ophthalmol. 2012;5:12. 63
Frijhoff J, Winyard PG, Zarkovic N, Davies SS, Stocker R, Cheng D, et al. Clinical relevance of biomarkers of oxidative stress. Antioxid Redox Signal. 2015;23:1144–70.
Halliwell B, Gutteridge JMC. Role of free radicals and catalytic metal ions in human diseases: an overview. Methods Enzymol. 1990;186:1–85.
Stadtman ER. Protein oxidation and aging. Science. 1992;257:1250–8.
Mozaffarieh M, Grieshaber MC, Flammer J. Oxygen and blood flow: players in the pathogenesis of glaucoma. Mol Vis. 2008;14:224–33.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Birer, S., Arda, H., Kilic, D. et al. Systemic oxidative stress in non-arteritic anterior ischemic optic neuropathy. Eye 33, 1140–1144 (2019). https://doi.org/10.1038/s41433-019-0388-0
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41433-019-0388-0
This article is cited by
-
Is the clinical course of non-arteritic ischemic optic neuropathy associated with oxidative damage and the dynamics of the antioxidant response?
International Ophthalmology (2023)
-
Systemic oxidative stress biomarkers in patients with vitreomacular traction syndrome
International Ophthalmology (2021)
